References

Adnan Khan, M. A. (2014). Performance of severity of illness classification for Clostridium difficile
infection to predict need-for-colectomy or inpatient death. Journal of Community Hospital
Internal Medicine Perspectives , 1-4.

Carrico, R. M., Bryant, K., & Limbago, B. (2013). Guide to Preventing Clostridium difficile Infection.
APIC Implementation Guide, 4-85.

Faten N Aberra, M. M. (2017). medscape. Retrieved from medscape journal:

https://emedicine.medscape.com/article/186458-overview#a1

henderson, r. (2016, Mei). gastoenterology. Retrieved from PATIENT ACCESS:

https://patient.info/doctor/pseudomembranous-colitis#nav-7

MD, T. N., John Y Kao, M., & F Jacob Seagull, P. (2016). Clostridium difficile Infection in Adults and
Children . 1-20.

offosu, A. (2016). Clostridium difficile infection: a review of current and emerging therapies . Annals
of Gastroenterology, 16(4), 147-154.

schoreder, m. (2015, maret 1). Chlostridium difficle associated diarrhea. american family physician,
71, 921.

Scott R. Steele, M., James McCormick, D., Genevieve B. Melton, M. I., David E. Rivadeneira, M., David
Stewart, M., W. Donald Buie, M., & Janice Rafferty, M. (2015). Practice Parameters for the
Management of Clostridium difficile Infection. disease of colon and rectum , 58(1).

skains, m. (2003, agustus ). clostidium difficle colitis .

Stuart H. Cohen, D. G. (2007). Clostridium difficileInfection: Clinical Practice Guidelines by SHEA and
IDSA. infectious disaease association of America .

Stuart H. Cohen, M., Dale N. Gerding, M., Stuart Johnson, M., Ciaran P. Kelly, M., Vivian G. Loo, M., L.
Clifford McDonald, M., . . . Mark H. Wilcox, M. (2010, may). Clinical Practice Guidelines for
Clostridium difficile. infection control and hospital epidemiology, 31(5), 432-450.

Surawicz, C. M., Brandt, L., Binion, D. G., Ananthakrishnan, A. N., & Curry, S. R. (2013). guideline for
diagnosis treatment and prevention of CDI . AMJ gastroenterology, 478-498.

Surawicza, C., & LynneV.McFarland. (2018). Pseudomembranous Colitis: Causes and Cures. 91-100.

(Faten N Aberra, 2017)

(offosu, 2016)

(schoreder, 2015)

(henderson, 2016)

(Carrico, Bryant, & Limbago, 2013)

(Surawicza & LynneV.McFarland, 2018)

(Adnan Khan, 2014)

(skains, 2003)

(Stuart H. Cohen, et al., 2010)

(Surawicz, Brandt, Binion, Ananthakrishnan, & Curry, 2013)

(Stuart H. Cohen D. G., 2007)

(MD, John Y Kao, & F Jacob Seagull, 2016)